NCT06754280 An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
| NCT ID | NCT06754280 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Illinois at Chicago |
| Condition | Chronic Kidney Disease(CKD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-03-13 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-03-13 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.
Eligibility Criteria
Inclusion Criteria: * Self-identifies as Black or African American * Age ≥35 to ≤80 years old * CKD Stage 1-4 * Self-reported 6 or more hours/day of sedentary time * Ability to speak/read/understand English * Has access to a telephone Exclusion Criteria: * Being unable to walk 1 block * Being unable to stand from a seated position without assistance * Using a wheelchair, walker, or cane for all of their ambulation * Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension * Kidney transplant * Any other condition that the investigator considers precludes participation in the trial * Participated in the Patient Advisory Board
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06754280 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 80 Years, studying Chronic Kidney Disease(CKD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06754280 currently recruiting?
Yes, NCT06754280 is actively recruiting participants. Contact the research team at mhanna22@uic.edu for enrollment information.
Where is the NCT06754280 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06754280 clinical trial?
NCT06754280 is sponsored by University of Illinois at Chicago. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.